<DOC>
	<DOCNO>NCT00372450</DOCNO>
	<brief_summary>RATIONALE : Placing stent esophagus may lessen swallow difficulty improve quality life patient malignant dysphagia cause esophageal cancer gastroesophageal junction cancer . PURPOSE : This randomized clinical trial study self-expanding plastic stent see well work compare self-expanding metal stent treat patient malignant dysphagia cause esophageal cancer gastroesophageal junction cancer .</brief_summary>
	<brief_title>Plastic Stents Compared With Metal Stents Treating Patients With Malignant Dysphagia Caused Esophageal Cancer Gastroesophageal Junction Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Assess difference baseline health-related quality life patient malignant dysphagia due cancer esophagus gastroesophageal junction palliate self-expanding plastic stent ( SEPS ) compare receive self-expanding metal stent ( SEMS ) . Secondary - Perform cost-effective analysis type stent independent evaluation rate SEPS-related SEMS-related morbidity necessitate repeat endoscopic intervention and/or additional healthcare cost patient . - Analyze effective palliation ( degree duration improvement dysphagia ) patient . - Determine individual rate complication associate type esophageal stent patient . OUTLINE : This randomize , control study . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo placement self-expanding metal stent day 1 . - Arm II : Patients undergo placement self-expanding plastic stent day 1 . Health-related quality life assess baseline , 30 day , 3 month . PROJECTED ACCRUAL : A total 90 patient accrue study .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary cancer esophagus gastroesophageal junction Squamous cell type Diagnosis malignant dysphagia Disease deem surgically inoperable , may follow : Locally contain Locally advance Metastatic Unresponsive previous chemoradiotherapy Recurrent despite previous surgical resection Must either inpatient OR outpatient Johns Hopkins Hospital No known tracheal compression tumor burden PATIENT CHARACTERISTICS : Karnofsky performance status 50100 % Life expectancy ≥ 6 month Platelet count &gt; 50,000/mm³ INR &lt; 1.5 PRIOR CONCURRENT THERAPY : See Disease Characteristics Prior surgery , chemotherapy , biologic therapy , radiotherapy allow No concurrent surgery , chemotherapy , biologic therapy , radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
	<keyword>gastrointestinal complication</keyword>
</DOC>